PW Medtech Group Limited (HKG:1358)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.300
+0.010 (0.78%)
Mar 5, 2026, 3:08 PM HKT
36.84%
Market Cap 1.89B
Revenue (ttm) 925.78M
Net Income (ttm) 160.60M
Shares Out 1.47B
EPS (ttm) 0.11
PE Ratio 12.09
Forward PE n/a
Dividend 0.10 (7.52%)
Ex-Dividend Date Nov 3, 2025
Volume 47,000
Average Volume 552,150
Open 1.300
Previous Close 1.290
Day's Range 1.300 - 1.310
52-Week Range 0.940 - 1.630
Beta 0.56
RSI 41.61
Earnings Date Mar 27, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical device... [Read more]

Sector Healthcare
Founded 1997
Employees 1,356
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1358
Full Company Profile

Financial Performance

In 2024, PW Medtech Group's revenue was 768.90 million, an increase of 13.90% compared to the previous year's 675.08 million. Earnings were 150.78 million, a decrease of -1.57%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.